Long-Acting Reversible Contraceptives Good for Teens

Share this content:
Long-Acting Reversible Contraceptives Good for Teens
Long-Acting Reversible Contraceptives Good for Teens

FRIDAY, April 27, 2018 (HealthDay News) -- Long-acting reversible contraceptives (LARC) are suitable for use by adolescents, according to a Committee Opinion published in the May issue of Obstetrics & Gynecology.

Noting that from 2006 to 2010, 82 percent of adolescents at risk of unintended pregnancy were using contraception but only 59 percent used a highly-effective method, researchers from the American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care address contraception among adolescents.

The researchers note that, compared with short-acting contraceptives, LARC have higher efficacy, continuation rates, and satisfaction rates among adolescents who choose to use them. Complications associated with intrauterine devices and contraceptive implants are rare, with little difference between adolescents and women, indicating that these methods are safe for adolescents. Patients' lack of familiarity with or understanding of these methods, potentially high cost of initiation, lack of access, low parental acceptance, and obstetrician-gynecologists' and other health care providers' misconceptions about LARC safety in adolescents are barriers to LARC use. Obstetrician-gynecologists should continue to follow standard guidelines for sexually transmitted infection (STI) screening because of the increased risk among adolescents. Adolescents who use LARC should be encouraged to use male or female condoms to reduce the risk of STIs.

"Obstetrician-gynecologists should counsel all sexually active adolescents who do not seek pregnancy on the range of reversible contraceptive methods, including LARC, and should help make these contraceptives readily accessible to them," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA: Gout Drug Uloric Increases Risk of Death

FDA: Gout Drug Uloric Increases Risk of Death

Medication is associated with increased risk of heart-related death and death from all causes

Since Early 2000s, Overdose Death Rates Are Highest in U.S.

Since Early 2000s, Overdose Death Rates Are Highest ...

U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s

National Health Spending Set to Increase 5.5 Percent Annually

National Health Spending Set to Increase 5.5 Percent ...

Long-observed demographic and economic factors expected to drive growth in health spending

is free, fast, and customized just for you!




Already a member?

Sign In Now »